These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32080809)

  • 21. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram Predicting Survival After Recurrence in Patients With Stage I to III Colon Cancer: A Nationwide Multicenter Study.
    Kawai K; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Sugihara K; Watanabe T
    Dis Colon Rectum; 2018 Sep; 61(9):1053-1062. PubMed ID: 30086054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
    Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
    Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
    BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less intensive surveillance after radical surgery for stage I-III colorectal cancer by focusing on the doubling time of recurrence.
    Miyake H; Kawai K; Nozawa H; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ishihara S
    Surg Today; 2021 Apr; 51(4):550-560. PubMed ID: 32935208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
    Midgley RS; McConkey CC; Johnstone EC; Dunn JA; Smith JL; Grumett SA; Julier P; Iveson C; Yanagisawa Y; Warren B; Langman MJ; Kerr DJ
    J Clin Oncol; 2010 Oct; 28(30):4575-80. PubMed ID: 20837956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.
    Dang H; de Vos Tot Nederveen Cappel WH; van der Zwaan SMS; van den Akker-van Marle ME; van Westreenen HL; Backes Y; Moons LMG; Holman FA; Peeters KCMJ; van der Kraan J; Langers AMJ; Lijfering WM; Hardwick JCH; Boonstra JJ
    Gastrointest Endosc; 2019 Mar; 89(3):533-544. PubMed ID: 30273589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram for predicting recurrence in stage II colorectal cancer.
    Hoshino N; Hasegawa S; Hida K; Kawada K; Ganeko R; Sugihara K; Sakai Y
    Acta Oncol; 2016 Dec; 55(12):1414-1417. PubMed ID: 27581839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.
    Sugawara K; Kawaguchi Y; Nomura Y; Koike D; Nagai M; Tanaka N
    World J Surg; 2017 Jan; 41(1):295-305. PubMed ID: 27464912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients.
    Bhome R; Peppa N; Karar S; McDonnell D; Mirnezami A; Hamady Z
    Eur J Surg Oncol; 2021 Jul; 47(7):1623-1628. PubMed ID: 33483238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies.
    Fuccio L; Rex D; Ponchon T; Frazzoni L; Dinis-Ribeiro M; Bhandari P; Dekker E; Pellisè M; Correale L; van Hooft J; Jover R; Libanio D; Radaelli F; Alfieri S; Bazzoli F; Senore C; Regula J; Seufferlein T; Rösch T; Sharma P; Repici A; Hassan C
    Gastroenterology; 2019 Apr; 156(5):1309-1323.e3. PubMed ID: 30553914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of locally or radically resected T1 colorectal cancer.
    Nam MJ; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Kim SY; Baek JY; Park SC; Oh JH
    Colorectal Dis; 2016 Sep; 18(9):852-60. PubMed ID: 26589573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia.
    Prabhakaran S; Kong JC; Chin M; Carne P; Farmer C; Skinner S; Warrier SK; Bell S
    Langenbecks Arch Surg; 2021 Dec; 406(8):2789-2796. PubMed ID: 34338847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
    Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
    JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer.
    Lavanchy JL; Vaisnora L; Haltmeier T; Zlobec I; Brügger LE; Candinas D; Schnüriger B
    Int J Colorectal Dis; 2019 Dec; 34(12):2091-2099. PubMed ID: 31709491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.